Not Yet Recruiting PHASE2 INTERVENTIONAL 3-arm
NCT06823544
A Comparative Single Blind Clinical Study on the Effect of Alvogyl, Eugenol, and Nigella Sativa (Black Seed Oil) for Alveolar Osteitis.
Sponsor: HITEC-Institute of Medical Sciences
Conditions
Alveolar Osteitis
Interventions
Alvogyl Eugenol Nigella Sativa Oil
Updated 1 time since 2025 Last updated: Feb 7, 2025 Started: Feb 1, 2025 Primary completion: Jul 31, 2025 Completion: Aug 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06823544, this PHASE2 trial focuses on Alveolar Osteitis and remains actively recruiting participants. Sponsored by HITEC-Institute of Medical Sciences, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- HITEC-Institute of Medical Sciences
Data source: HITEC-Institute of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .